Unannotated small RNA clusters in circulating extracellular vesicles detect early stage liver cancer
Johann von Felden,Teresa Garcia-Lezana,Navneet Dogra,Edgar Kozlova,Mehmet Eren Ahsen,Amanda J. Craig,Stacey Gifford,Benjamin Wunsch,Joshua T. Smith,Sungcheol Kim,Jennifer E. L. Diaz,Xintong Chen,Ismail Labgaa,Philipp K. Haber,Reena Olsen,Dan Han,Paula Restrepo,Delia D’Avola,Gabriela Hernandez-Meza,Kimaada Allette,Robert Sebra,Behnam Saberi,Parissa Tabrizian,Amon Asgharpour,Douglas Dieterich,Josep M Llovet,Carlos Cordon-Cardo,Ash Tewari,Myron Schwartz,Gustavo Stolovitzky,Bojan Losic,Augusto Villanueva
DOI: https://doi.org/10.1101/2020.04.29.066183
2020-05-02
Abstract:ABSTRACT Background Hepatocellular carcinoma (HCC) is among the deadliest malignancies and surveillance tools for early detection are suboptimal. Extracellular vesicles (EVs) have gained increasing scientific interest due to their involvement in tumor initiation and metastasis, however, most extracellular RNA (exRNA) biomarker studies are limited to annotated genomic regions. Methods EVs were isolated with ultracentrifugation and nanoDLD and quality assessed by electron microscopy, immunoblotting, nanoparticle tracking, and deconvolution analysis. We performed genome-wide small exRNA sequencing, including unannotated transcripts. We identified small RNA clusters (smRCs) and delineated their key genomic features across biospecimens (blood, urine, tissue) and EV isolation techniques. A 3-smRC signature for early HCC detection was trained and validated in two independent cohorts. Results EV-derived smRCs were dominated by uncharacterized, unannotated small RNA and uniformly tiled across the genome with a consensus sequence of 20bp. A 3-smRC signature was significantly overexpressed in circulating EVs of HCC patients compared to controls at risk or patients with non-HCC malignancies (p<0.01, n=157). An independent validation in a phase 2 biomarker study revealed 86% sensitivity and 91% specificity for the detection of early HCC from controls at risk (i.e. cirrhosis or chronic liver disease, n=209) (positive predictive value (PPV): 89%, area under the ROC curve [AUC]: 0.87). The 3-smRC signature was independent of alpha-fetoprotein (p<0.0001) and a composite model yielded an increased AUC of 0.93 (sensitivity: 85%, specificity: 94%, PPV: 95%). Conclusion An exRNA-based 3-smRC signature from plasma detects early stage HCC, which directly leads to the prospect of a minimally-invasive, blood-only, operator-independent surveillance biomarker. One sentence summary We employ a novel, data-driven approach to identify and characterize small RNA clusters from unannotated loci in extracellular vesicle-derived RNA across different cancer types, isolation techniques, and biofluids, facilitating discovery of a robust biomarker for detection of early stage liver cancer.